Company Filing History:
3 out of 17 
2 out of 2,106 
1 out of 846 
Years Active: 2006-2010
Title: Thomas Seebeck: Innovator in Nucleic Acid Research
Introduction
Thomas Seebeck is a notable inventor hailing from Ortschwaben, Switzerland. He has made significant contributions to the field of molecular biology, particularly in the study of cyclic nucleotide-specific phosphodiesterases. With a total of 3 patents to his name, Seebeck's work has implications for the diagnosis and treatment of various disorders.
Latest Patents
Seebeck's latest patents focus on novel amino acid and nucleic acid sequences of cyclic nucleotide-specific phosphodiesterases derived from parasites. The inventions encompass nucleic acid constructs, vectors, and host cells that incorporate these sequences. Additionally, they detail methods for producing and utilizing these sequences, as well as antibodies that target them. Another patent provides isolated full-length nucleic acid molecules encoding a novel PDE protein, along with methods for their application. These innovations are crucial for diagnosing, preventing, or treating conditions linked to the presence or deficiency of these novel PDE proteins.
Career Highlights
Throughout his career, Thomas Seebeck has been associated with prestigious institutions such as the University of Bern and the University of Washington. His research has significantly advanced the understanding of phosphodiesterases and their roles in various biological processes.
Collaborations
Seebeck has collaborated with esteemed colleagues, including Joseph A. Beavo and Scott Haydn Soderling. These partnerships have fostered a rich environment for innovation and discovery in the field of molecular biology.
Conclusion
Thomas Seebeck's contributions to the field of nucleic acid research and his innovative patents highlight his role as a leading inventor. His work continues to influence the diagnosis and treatment of disorders related to phosphodiesterases.